VRTX Vertex Pharmaceuticals Inc. / Ma

Fundamentals / CIK 0000875320 / USD

Vertex Pharmaceuticals Inc. / Ma reported $12.95B in revenue and net income of $3.98B for the trailing twelve months ended September 30, 2026 (up 11.8% year over year), with a 85.5% gross margin and a 33.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VRTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$11.89B$5.94B$0-$1.52BFY 2016 Revenue: $1.70BFY 2016 Net Income: -$112.1M2016FY 2017 Revenue: $2.49BFY 2017 Net Income: $263.5M2017FY 2018 Revenue: $3.05BFY 2018 Net Income: $2.10B2018FY 2019 Revenue: $4.16BFY 2019 Net Income: $1.18B2019FY 2020 Revenue: $6.21BFY 2020 Net Income: $2.71B2020FY 2021 Revenue: $7.57BFY 2021 Net Income: $2.34B2021FY 2022 Revenue: $8.93BFY 2022 Net Income: $3.32B2022FY 2023 Revenue: $9.87BFY 2023 Net Income: $3.62B2023FY 2024 Revenue: $11.02BFY 2024 Net Income: -$535.6M2024FY 2025 Revenue: $12.00BFY 2025 Net Income: $3.95B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $12.00B $11.02B $9.87B $8.93B $7.57B $6.21B $4.16B $3.05B $2.49B $1.70B
Cost of Revenue $1.65B $1.53B $1.26B $1.08B $904.2M $736.3M $547.8M $409.5M $275.1M $210.5M
Gross Profit $10.35B $9.49B $8.61B $7.85B $6.67B $5.47B $3.62B $2.64B $2.21B $1.49B
Research & Development $3.91B $3.63B $3.16B $2.54B $3.05B $1.83B $1.75B $1.42B $1.32B $1.05B
Selling, General & Admin $1.75B $1.46B $1.14B $944.7M $840.1M $770.5M $658.5M $557.6M $496.1M $432.8M
Operating Income $4.17B -$232.9M $3.83B $4.31B $2.78B $2.86B $1.20B $635.1M $123.2M $9.94M
EBITDA $4.38B -$25.70M $4.01B $4.46B $2.91B $2.97B $1.30B $707.6M $184.6M $71.33M
Interest Income $490.9M $598.1M $614.7M $144.6M $4.90M $22.20M $63.70M $38.35M $11.75M --
Interest Expense $13.30M $30.60M $44.10M $54.80M -- $58.15M $58.50M $72.47M $69.30M --
Income Before Tax $4.64B $248.5M $4.38B $4.23B $2.73B $3.12B $1.39B $600.2M -$15.69M -$67.37M
Income Tax Expense $690.0M $784.1M $760.2M $910.4M $388.3M $405.2M $218.1M -$1.49B -$107.3M $16.66M
Net Income $3.95B -$535.6M $3.62B $3.32B $2.34B $2.71B $1.18B $2.10B $263.5M -$112.1M
Basic EPS $15.46 -$2.08 $14.05 $12.97 $9.09 $10.44 $4.58 $8.24 $1.06 -$0.46
Diluted EPS $15.32 -$2.08 $13.89 $12.82 $9.01 $10.29 $4.51 $8.09 $1.04 -$0.46
Basic Shares Outstanding 255.7M 257.9M 257.7M 256.1M 257.7M 259.8M 256.7M 254.3M 248.9M 244.7M
Diluted Shares Outstanding 258.0M 257.9M 260.5M 259.1M 259.9M 263.4M 260.7M 259.2M 253.2M 244.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $3.44B $3.33B $2.99B $3.19B $3.08B $2.96B $2.77B $2.91B
Cost of Revenue $526.1M $489.2M $392.8M $466.0M $414.8M $407.5M $363.0M $423.4M
Gross Profit $2.91B $2.84B $2.59B $2.72B $2.66B $2.56B $2.41B $2.49B
Research & Development $1.32B $993.8M $961.6M $973.7M $977.7M $978.4M $979.7M $998.7M
Selling, General & Admin $844.1M $582.2M $493.7M $487.0M $445.1M $424.6M $396.4M $377.6M
Operating Income $712.9M $1.25B $1.14B $1.21B $1.19B $1.15B $630.1M $1.03B
EBITDA $782.1M $1.30B $1.19B $1.26B $1.24B $1.20B $678.5M $1.07B
Interest Income $118.4M -- -- $121.9M $125.7M $122.4M $120.9M $128.2M
Interest Expense $36.00M -- -- $3.30M $3.30M $3.70M $3.00M $2.80M
Income Before Tax $783.4M $1.39B $1.25B $1.33B $1.30B $1.28B $730.4M $1.14B
Income Tax Expense $129.8M $292.0M $221.5M $139.9M $215.9M $250.1M $84.10M $223.5M
Net Income $653.6M $1.10B $1.03B $1.19B $1.08B $1.03B $646.3M $913.0M
Basic EPS $2.58 $4.34 $4.06 -- $4.24 $4.02 $2.52 --
Diluted EPS $2.56 $4.31 $4.02 -- $4.20 $3.99 $2.49 --
Basic Shares Outstanding 253.5M 253.7M 254.1M -- 255.6M 256.7M 256.9M --
Diluted Shares Outstanding 255.2M 255.2M 256.3M -- 257.6M 258.9M 259.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 1 Dec 31 Jan 1
Cash & Cash Equivalents $5.08B $4.57B $10.37B $10.50B $6.79B $5.99B $3.11B -- $2.65B --
Short-Term Investments $1.52B $1.55B $849.2M $274.5M $729.9M $670.7M $699.0M -- $518.1M --
Cash & Short-Term Investments $6.61B $6.12B $11.22B $10.78B $7.52B $6.66B $3.81B -- $3.17B --
Accounts Receivable, Net $2.05B $1.61B $1.56B $1.44B $1.14B $885.4M $633.5M -- $409.7M $311.2M
Inventory $1.69B $1.21B $738.8M $460.6M $353.1M $280.8M $167.5M -- $124.4M $111.7M
Other Current Assets $110.9M $76.40M $84.30M $74.40M $59.20M $79.70M -- -- $61.59M --
Total Current Assets $11.20B $9.60B $14.14B $13.23B $9.56B $8.13B $4.82B -- $3.84B --
Property, Plant & Equipment, Net $1.52B $1.23B $1.16B $1.11B $1.09B $958.5M $745.1M $758.1M $812.0M --
Goodwill $1.09B $1.09B $1.09B $1.09B $1.00B $1.00B $1.00B -- $50.38M --
Intangible Assets $424.2M $825.9M $839.9M $603.6M $400.0M $400.0M $400.0M -- $0 --
Long-Term Investments $5.71B $5.11B $2.50B $112.2M -- -- -- -- -- --
Other Non-Current Assets $1.24B $999.3M $895.3M $409.6M $110.8M $49.30M $69.38M -- $40.73M --
Total Non-Current Assets $14.44B $12.94B $8.59B $4.92B $3.87B $3.62B $3.50B -- $2.40B --
Total Assets $25.64B $22.53B $22.73B $18.15B $13.43B $11.75B $8.32B $6.26B $6.25B $3.56B
Accounts Payable $461.7M $413.0M $364.9M $303.9M $195.0M $155.1M $87.61M -- $111.0M --
Short-Term Debt $0 -- -- -- -- -- -- -- -- --
Other Current Liabilities $428.3M $363.0M $527.2M $311.5M $268.4M $317.4M $130.3M -- $50.41M $36.46M
Total Current Liabilities $3.86B $3.56B $3.55B $2.74B $2.14B $1.88B $1.33B -- $1.12B --
Long-Term Debt $0 -- -- -- -- -- -- -- -- --
Other Non-Current Liabilities $1.27B $1.01B $877.7M $685.8M $303.3M $108.4M $99.03M $70.23M $108.9M --
Total Non-Current Liabilities $3.12B $2.56B $1.60B $1.50B $1.19B $1.19B $898.4M -- $690.4M --
Total Liabilities $6.98B $6.12B $5.15B $4.24B $3.33B $3.06B $2.23B -- $1.81B --
Total Debt (incl. Leases) $2.04B $1.75B $808.4M $899.7M $967.4M $942.5M $673.2M $634.3M $596.6M --
Common Stock $2.50M $2.60M $2.60M $2.60M $2.50M $2.60M $2.59M -- $2.55M --
Retained Earnings $13.56B $9.61B $10.14B $6.52B $3.20B $858.7M -$1.85B -$3.03B -$2.99B -$5.11B
Accumulated Other Comp. Income -$15.90M $127.8M -$14.30M $800K $15.90M -$68.50M -$1.97M -- $659K -$10.62M
Total Stockholders' Equity $18.67B $16.41B $17.58B $13.91B $10.10B $8.69B $6.09B -- $4.44B --
Total Equity $18.67B $16.41B $17.58B $13.91B $10.10B $8.69B $6.09B -- $4.44B --

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.98B $6.14B $5.49B $5.08B $4.94B $4.97B $4.67B $4.57B
Short-Term Investments $1.32B $1.71B $1.75B $1.52B $1.35B $1.41B $1.53B $1.55B
Cash & Short-Term Investments $6.30B $7.85B $7.25B $6.61B $6.29B $6.38B $6.20B $6.12B
Accounts Receivable, Net $2.31B $2.13B $2.00B $2.05B $1.95B $1.89B $1.81B $1.61B
Inventory $2.25B $1.77B $1.77B $1.69B $1.63B $1.50B $1.36B $1.21B
Other Current Assets -- -- -- $110.9M -- -- -- $76.40M
Total Current Assets $11.69B $12.54B $11.73B $11.20B $10.57B $10.43B $10.01B $9.60B
Property, Plant & Equipment, Net $1.71B $1.67B $1.61B $1.52B $1.43B $1.34B $1.30B $1.23B
Goodwill $2.42B $1.09B $1.09B $1.09B $1.09B $1.09B $1.09B $1.09B
Intangible Assets $8.52B $412.8M $418.5M $424.2M $429.8M $435.5M $441.2M $825.9M
Long-Term Investments $3.52B $5.79B $5.75B $5.71B $5.72B $5.65B $5.16B $5.11B
Other Non-Current Assets $1.31B $1.25B $1.26B $1.24B $1.10B $1.08B $1.01B $999.3M
Total Non-Current Assets $21.05B $14.88B $14.75B $14.44B $14.29B $13.61B $12.87B $12.94B
Total Assets $32.74B $27.42B $26.48B $25.64B $24.86B $24.04B $22.88B $22.53B
Accounts Payable $472.6M $429.5M $489.3M $461.7M $420.3M $442.3M $445.0M $413.0M
Short-Term Debt $999.6M -- -- $0 -- -- -- --
Other Current Liabilities $293.0M $329.4M $407.1M $428.3M $441.5M $425.4M $386.4M $363.0M
Total Current Liabilities $5.00B $3.94B $3.88B $3.86B $4.48B $4.14B $3.78B $3.56B
Long-Term Debt $3.50B -- -- $0 -- -- -- --
Other Non-Current Liabilities $1.35B $1.26B $1.26B $1.27B $1.23B $1.20B $951.9M $1.01B
Total Non-Current Liabilities $6.83B $3.24B $3.24B $3.12B $3.07B $2.72B $2.60B $2.56B
Total Liabilities $11.83B $7.18B $7.12B $6.98B $7.54B $6.86B $6.38B $6.12B
Total Debt (incl. Leases) $6.48B $1.98B $1.99B $2.04B $1.83B $1.53B $1.65B $1.75B
Common Stock $2.50M $2.50M $2.50M $2.50M $2.50M $2.60M $2.60M $2.60M
Retained Earnings $16.34B $15.69B $14.59B $13.56B $12.37B $11.29B $10.25B $9.61B
Accumulated Other Comp. Income $57.20M $48.50M $24.80M -$15.90M -$64.50M -$101.1M $68.10M $127.8M
Total Stockholders' Equity $20.91B $20.25B $19.36B $18.67B $17.32B $17.18B $16.50B $16.41B
Total Equity $20.91B $20.25B $19.36B $18.67B $17.32B $17.18B $16.50B $16.41B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $3.95B -$535.6M $3.62B $3.32B $2.34B $2.71B $1.18B $2.09B $91.64M -$84.03M
Depreciation & Amortization $209.8M $207.2M $181.3M $148.3M $125.6M $109.5M $106.9M $72.42M $61.40M $61.40M
Stock-Based Compensation $685.9M $698.5M $581.2M $491.3M $441.4M $429.5M $360.5M $325.0M $293.2M $240.6M
Change in Receivables -$347.3M -$99.30M -$84.10M -$358.6M -$274.7M -$223.4M -$225.6M -$108.2M -$71.76M -$39.09M
Change in Inventory -$524.2M -$517.3M -$322.9M -$136.4M -$92.80M -$132.0M -$64.00M -$31.96M -$47.48M -$19.37M
Change in Payables $36.80M $49.50M $48.70M $120.8M $31.90M $51.30M -$22.80M $36.55M $8.75M -$11.74M
Operating Cash Flow $3.63B -$492.6M $3.54B $4.13B $2.64B $3.25B $1.57B $1.27B $844.9M $236.1M
Capital Expenditure -$437.6M -$297.7M -$200.4M -$204.7M -$235.0M -$259.8M -$75.40M -$95.45M -$99.42M -$56.56M
Free Cash Flow $3.19B -$790.3M $3.34B $3.93B $2.41B $2.99B $1.49B $1.17B $745.5M $179.5M
Acquisitions, Net -- $0 $0 -$295.9M $0 $0 -$1.15B $0 $0 --
Purchases of Investments -$6.40B -$7.44B -$3.79B -$692.7M -$528.2M -$431.4M -$537.2M -$431.9M -- --
Sales & Maturities of Investments -- -- -- -- -- -- $475.9M -- -- --
Investing Cash Flow -$945.4M -$3.77B -$3.14B -$321.1M -$340.9M $99.40M -$1.24B -$202.2M -$483.3M $51.24M
Share Repurchases -$2.02B -$1.18B -$427.6M $0 -$1.43B -$539.1M -$186.0M -$350.0M $0 $0
Financing Cash Flow -$2.26B -$1.49B -$562.2M -$67.70M -$1.48B -$505.3M $126.8M -$71.22M $68.40M $133.3M
Net Change in Cash $515.6M -$5.80B -$139.7M $3.71B $811.2M $2.87B $462.4M $990.7M $435.8M $415.9M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $653.6M $1.10B $1.03B $1.19B $1.08B $1.03B $646.3M $913.0M
Depreciation & Amortization $69.20M $56.50M $55.90M $55.70M $54.00M $51.70M $48.40M $46.50M
Stock-Based Compensation $174.4M $170.2M $166.4M $157.6M $194.9M $167.3M $166.1M $167.8M
Change in Receivables -$173.8M -$140.2M $39.80M -$99.40M -$59.90M -$18.40M -$169.6M $69.00M
Change in Inventory -$34.20M -$27.70M -$97.70M -$77.40M -$131.1M -$148.6M -$167.1M -$147.5M
Change in Payables $40.90M -$66.70M $35.60M $38.30M -$35.30M $7.60M $26.20M $8.40M
Operating Cash Flow $643.1M $1.13B $1.43B $498.0M $1.24B $1.07B $818.9M $584.6M
Capital Expenditure -$97.30M -$112.2M -$133.4M -$149.4M -$101.8M -$145.7M -$40.70M -$92.60M
Free Cash Flow $545.8M $1.01B $1.29B $348.6M $1.14B $927.4M $778.2M $492.0M
Purchases of Investments -$1.10B -$2.36B -$2.51B -$1.23B -$1.35B -$2.17B -$1.65B -$2.16B
Investing Cash Flow -$6.10B -$45.80M -$431.9M -$288.1M -$117.0M -$484.5M -$55.80M -$821.9M
Share Repurchases -$126.7M -$469.5M -$336.9M -$128.4M -$1.07B -$391.8M -$426.1M -$417.9M
Financing Cash Flow $4.30B -$426.7M -$538.8M -$77.20M -$1.15B -$349.2M -$680.4M -$391.3M
Net Change in Cash -$1.17B $649.2M $417.1M $140.0M -$34.20M $296.6M $113.2M -$675.9M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 86.2% 86.1% 87.2% 87.9% 88.1% 88.1% 86.8% 86.6% 88.9% 87.6%
Operating Margin 34.8% -2.1% 38.8% 48.2% 36.7% 46.0% 28.8% 20.8% 5.0% 0.6%
Net Profit Margin 32.9% -4.9% 36.7% 37.2% 30.9% 43.7% 28.3% 68.8% 10.6% -6.6%
Return on Equity (ROE) 21.2% -3.3% 20.6% 23.9% 23.2% 31.2% 19.3% 47.3% 13.0% -9.7%
Return on Assets (ROA) 15.4% -2.4% 15.9% 18.3% 17.4% 23.1% 14.1% 33.6% 7.4% -3.9%
Current Ratio 2.90x 2.69x 3.99x 4.83x 4.46x 4.33x 3.61x 3.43x 3.28x 2.31x
Quick Ratio 2.46x 2.35x 3.78x 4.66x 4.30x 4.18x 3.49x 3.32x 3.14x 2.21x
Debt to Equity 0.11x 0.11x 0.05x 0.06x 0.10x 0.11x 0.11x 0.13x -- --
Revenue Growth (YoY) +8.9% +11.7% +10.5% +17.9% +22.1% +49.1% +36.6% +22.5% +46.2% +64.9%
Gross Profit Growth (YoY) +9.1% +10.3% +9.6% +17.7% +22.0% +51.3% +37.0% +19.2% +48.4% +63.0%
Operating Income Growth (YoY) -- -106.1% -11.0% +54.8% -2.6% +138.5% +88.5% +415.4% +1140.4% --
Net Income Growth (YoY) -- -114.8% +9.0% +41.8% -13.6% +130.4% -43.9% +695.8% -- --
EPS Growth (YoY) -- -114.8% +8.3% +42.7% -12.9% +127.9% -44.4% +677.4% -- --
Operating Cash Flow Growth (YoY) -- -113.9% -14.3% +56.2% -18.7% +107.3% +23.5% +50.3% +257.9% --
Free Cash Flow Growth (YoY) -- -123.7% -15.0% +63.0% -19.5% +100.4% +27.2% +57.6% +315.2% --
5Y Revenue / Share Growth +96.5% +163.5% +219.6% +248.7% +322.5% +458.4% +557.4% +122.4% +38.8% +1.0%
10Y Revenue / Share Growth +997.1% +1632.3% +610.7% +384.0% +326.9% +3238.8% +2657.6% +859.8% -- --
5Y Net Income / Share Growth +48.1% -145.3% +70.3% +1125.1% -- -- -- -- -- -417.3%
10Y Net Income / Share Growth -- -- -- -- +6196.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 85.5% 86.0% 86.2% 86.2% 86.3% 86.1% 86.0% 86.1%
Operating Margin 33.2% 38.0% 38.3% 34.8% 34.1% 34.4% -6.7% -2.1%
Net Profit Margin 30.7% 35.0% 35.5% 32.9% 31.3% 31.9% -8.9% -4.9%
Return on Equity (ROE) 19.0% 21.8% 22.4% 21.2% 21.2% 21.2% -6.0% -3.3%
Return on Assets (ROA) 12.1% 16.1% 16.4% 15.4% 14.8% 15.1% -4.3% -2.4%
Current Ratio 2.34x 3.19x 3.02x 2.90x 2.36x 2.52x 2.65x 2.69x
Quick Ratio 1.89x 2.74x 2.57x 2.46x 2.00x 2.16x 2.29x 2.35x
Debt to Equity 0.31x 0.10x 0.10x 0.11x 0.11x 0.09x 0.10x 0.11x
Revenue Growth (YoY) +11.8% +12.5% +7.8% +9.5% +11.0% +12.1% +3.0% +15.7%
Gross Profit Growth (YoY) +9.5% +11.2% +7.8% +9.5% +11.9% +12.5% +2.5% +15.8%
Operating Income Growth (YoY) -39.9% +8.3% +80.6% +17.5% +6.3% -- -44.7% +3.8%
Net Income Growth (YoY) -39.6% +6.5% +59.6% +30.5% +3.6% -- -41.2% -5.8%
EPS Growth (YoY) -39.2% +8.0% +61.1% -- +4.7% -- -40.8% --
Operating Cash Flow Growth (YoY) -48.2% +4.9% +74.4% -14.8% -9.4% -- -37.3% +149.2%
Free Cash Flow Growth (YoY) -52.1% +9.3% +66.4% -29.1% -12.5% -- -37.2% +178.8%
Source: SEC EDGAR CompanyFacts (CIK 0000875320) · from December 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:01 UTC · Open in terminal